Clinical Trial Update: Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an L-carnitine-containing peritoneal dialysis solution for improving insulin sensitivity in patients with end-stage renal dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Insulin Resistance

Drugs mentioned

• L-carnitine-containing peritoneal dialysis solution (L-carnitine-containing PD solution)

Snippet

Sponsor: Iperboreal Pharma Srl | Conditions: End Stage Renal Disease, Insulin Resistance | Phase 2 | Status: COMPLETED